Menstrual Blood Test Could Simplify HPV Screening
-
By
February 13, 2026
-
3 min
A community-based study in China demonstrates that testing menstrual blood collected on sanitary pads can accurately detect high-risk human papillomavirus (HPV), comparable to clinician-collected cervical samples. This non-invasive method could enhance cervical cancer screening, especially in low-resource settings where barriers like discomfort with pelvic exams exist. The study supports menstrual blood testing as a viable alternative that aligns with women's natural physiology, and shows potential to improve screening coverage without compromising diagnostic accuracy.
1. Menstrual blood can be used to test for high-risk HPV. 2. Study involved over 3,000 menstruating women. 3. Non-invasive method may increase screening accessibility. 4. High negative predictive value for serious disease. 5. Study suggests integration into existing diagnostic pathways. 6. Addresses barriers to traditional HPV testing. 7. Compatible with current HPV DNA testing platforms.
Listen Tab content